To evaluate the effect of miR-30e on NSCLC patientprognosis after treatment with EGFR-TKI, the Kaplan-Meier method and log-rank test were used to examine normalized miR-30e levelsand Disease free survival (DFS). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.